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Abstract: Malaria threatens the lives of more than one third of the world’s population; it is a major cause of human 
deaths. As a result of the emergence of resistant strains of Plasmodium falciparum to common antimalarial drugs, 
the search for new antimalarial drugs is urgently needed. Hemozoin synthesis is an indispensable process for the 
parasite survival and is the target of action for several known antimalarial drugs. Sage, Salvia palaestina, is an 
aromatic Mediterranean plant. Its leaves have been used over centuries in Palestinian traditional medicine and are 
now being investigated for potential antimalarial activity. This study reveals the antimalarial activity of crude and 
HPLC separated fractions tested using two methods; the inhibition of ferriprotoporphyrin IX (FP) bio-
mineralization: semi-quantitative micro-assay used by Deharo and a previously self-developed quantitative in vitro 
method. Reversed phase preparative liquid chromatography coupled to Photo Diode Array (PDA) detector was used 
to isolate and enrich eight fractions. Three fractions showed promising antimalarial activity. The crude alcoholic 
extract of sage leaves seems to have the potential of an antimalarial drug; it prevents β-hematin formation with an 
efficiency of about 72% when compared to the standard Chloroquine which gave 93% at comparable concentrations 
of chloroquine and extract. 
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INTRODUCTION 
 
Malaria is a disease of poverty, where it is 
concentrated in the tropical areas mostly of developing 
countries; it is one of the most prevalent parasitic 
diseases. According to the latest WHO estimates, there 
were about 219 million cases of malaria in 2010 and an 
estimated 660,000 deaths. Africa is the most affected 
continent with about 90% of all malaria deaths (World 
Malaria Report (WMR), 2012). 
Plasmodium; the parasite causing malaria, is the 
single most devastating protozoan (Bannister and 
Sherman, 2009). There are five species of plasmodium 
that may cause human malaria, but Plasmodium 
falciparum is the most highly fatal species (Rathore, 
2006).  
In nature, Plasmodium is transmitted from one host 
to another by a bite of an infected female Anopheles 
mosquito to a human victim where thousands of 
sporozoites may enter the body. Once inside, 
sporozoites travel to the liver, producing thousands of 
merozoits within a week then migrating back into the 
blood stream where they invade and infect erythrocytes. 
During this intra-erythrocytic stage the parasites 
consume intercellular proteins, mainly hemoglobin, as a 
source of amino acids. Digestion of hemoglobin takes 
place within food vacuoles of the parasite where pH 
ranges between 5.0-5.4 (Goldberg et al., 1990). Inside 
the RBC the parasites multiply to form more merozoits, 
the infected red blood cells then burst releasing the 
newly formed merozoits thus infecting new cells 
(Bannister and Sherman, 2009). 
The intra-erythrocytic stage appears to be 
fundamental to the Plasmodium life cycle. Massive 
degradation of hemoglobin results the liberation of 
monomeric heme which is highly toxic to the parasite. 
In order to survive, this parasite, as other blood 
parasites, have evolved a unique mechanism for heme 
detoxification through its conversion into an uncreative, 
nontoxic, insoluble crystalline pigment, known as 
hemozoin (Egan et al., 2002). 
Structurally, hemozoin consists of reciprocal head-
to-tail dimeric units of heme bound through propionate 
oxygen-Iron (III) (Slater et al., 1991; Pagola et al., 
2000). The propionic acid groups of the heme dimer 
then hydrogen-bond with other dimers to form extended 
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crystals. Disruption of this crystallization process 
results in parasite death (Rathore, 2006), this serves as 
an important strategy for drug design and a target for 
action  of  several  known  antimalarial drugs (Hawley 
et al., 1998; Sullivan et al., 1996).  
A synthetic analouge to hemozoin called β-hematin 
is considered to be structurally and spectroscopically 
identical to purified hemozoin (Slater et al., 1991), 
making it an excellent target for biochemistry studies 
(Tekwani and Walker, 2005; Ncokazi and Egan, 2005). 
Since Plasmodium species have become resistant 
to many antimalarial drugs; risk of infection is 
increasing. Plasmodium has developed resistance to 
drugs in the aminoquinoline group: chloroquine, 
amodiaquine and mefloquine. Recently resistance to 
Artemisinin derivatives used in combination therapy 
has been reported (Dondorp et al., 2009), making the 
development of new antimalarial drugs much more 
urgent. 
We had previously attempted to find new anti-
malarial drugs in concentrating on the effect of 
Pyrimidine derivatives in the in-vitro inhibition of β-
hematin (Aljazzar et al., 2010) and cis-platin complexes 
(Akkawi et al., 2012). In this study however we 
concentrate on the effect of new isolated molecules 
from Palestinian herbal plants. 
Palestinian sage, which is known as Salvia 
palaestina belongs to the family Lamiaceae is an 
important aromatic medicinal herb that is widely used 
today in the form of herbal tea. Previous studies showed 
that Salvia palaestina essential oils and extracts have 
excellent anti-oxidant (Gürsoy et al., 2012), anti-
bacterial (Karataş and Ertekin, 2010) and anti-
proliferative (Fiore et al., 2006) properties. . However, 
no studies on the in-vitro antimalarial activity of this 
plant have been carried out thus far. In a continuation to 
verify the efficacy of traditional medicines against 
malaria, Salvia palaestina was investigated. 
The target of this investigation is to develop a rapid 
analytical HPLC method that scans the active 
constituents from 35% ethanolic crude Salvia 
palaestina followed by enrichment and isolation of the 
active antimalarial fractions by using reversed phase 
preparative chromatography coupled with photo diode 
array detector. The isolated fractions were tested for 
their antimalarial activity.  
 
MATERIALS AND METHODS 
 
Plant collection: Fresh wild sage leaves (Salvia 
palaestina) were collected towards the end of March 
from different areas around Jerusalem and the West 
Bank of Palestine far from agricultural lands. Samples 
were air dried in the shade for ten days.  
 
Materials: Glacial acetic acid (HPLC grade), 
acetonitrile (ACN) and Ethanol (EtOH) solvents were 
purchased from Merck (Germany). Hemin chloride and 
all other products were analytical reagent grade 
obtained from Sigma. Highly purified water was 
prepared by using a Millipore Milli-Q plus water 
purification system.  
 
Extraction of the nonvolatile secondary metabolites 
of Salvia palaestina: Dried leaves were grinded into 
powder, extraction was performed by soaking (1:10) 
(wt/vol) of dried plant leaves in 35% ethanol, left for 
about 24 h at room temperature. The extract was then 
filtered using what man No 42 filter paper. The crude 
ethanol extract was obtained after the solvent was 
rotary evaporated at 60-80°C under reduced pressure, 
followed by lyophilization using a Labconco freeze 
drier until constant weight was obtained then stored at -
20C until use.  
 
In-vitro semi-quantitative method: The method 
adopted was according to Deharo et al. (2002). A 
mixture containing 50 μL of 0.5 mg/mL hemin chloride 
freshly dissolved in Dimethylsulphoxide (DMSO), 100 
μL of 0.5 M sodium acetate buffer (pH 4.4) and 50 μL 
of potential anti-malarial drug solution or solvent, was 
incubated in a non-sterile 96-well flat bottom plate at 
37ºC for 18-24 h. The solutions were added to the plate 
in the above order. The plate was then centrifuged for 
10 min at 4000 rpm. The supernatant was removed and 
the pH of reaction was measured. The final pH of the 
mixture was between (5.0-5.2). The wells were washed 
with 200 μL DMSO per well to remove free hemin 
chloride. The plate was centrifuged again followed by 
discharging the supernatant. The β-hematin remaining 
was then dissolved in 200 μL of 0.1 M NaOH to form 
an alkaline hematin that can be measured 
spectrophotometrically at 405 nm using ELISA reader.  
Ultra pure water was used as negative control, 
positive controls and tested extracts were dissolved in 
ultra-pure water. 
 
In-vitro quantitative method: According to Blauer and 
Akkawi (1997), freshly prepared stock solution of 
hemin chloride was prepared by dissolving the salt in 
0.4 M aqueous NaOH and incubated for 30 min at 
37°C, stock solution of the leaf extract used was 
prepared using ultra-pure water. The final concentration 
of hemin and Salvia palaestina leaf crude ethanol 
extract were 0.5 and 1 mg/mL respectively, aqueous 
HCl was also included in order to obtain the required 
pH (ionic strength was 0.1235 M). The reaction was 
equilibrated at 37°C for 10 min, finally 4 µL of glacial 
acetic acid were added with gentle mixing (Blauer and 
Akkawi, 2000). The whole mixture was left for 2 h at 
37°C without stirring. The total volume of the reaction 
mixture was 4 mL and the final pH was 4.9 to 5.2. 
Samples were centrifuged for 10 min using (Jouan B4) 
centrifuge. The supernatant was discarded and the 
precipitate was washed with ultra-pure water and 
quantitatively transferred to a Millipore Swinnex 13 
filter containing Whatman filter paper No. 50, already 
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lyophilized to a constant weight in freeze-drying 
machine (Labconco Freezone). DMSO was passed 
slowly through the filter until the filtrate remained 
feebly colored and then washed again with ultra-pure 
water. The remaining precipitate was then lyophilized 
to a constant weight. 
 
HPLC instrumentation systems: The Analytical High 
Pressure Liquid Chromatography (HPLC-PDA) system 
consists of an alliance 2695 HPLC, 2996-Photo Diode 
Array (PDA). Data acquisition and control were carried 
out using Empower™ software (Waters Company, 
Germany). The Preparative High Pressure Liquid 
Chromatography (Prep-HPLC-PDA) system consisted 
of 3535 quaternary gradient module which provides a 
flow rate of up to 50 mL/min, equipped with 996 PDA 
detectors.  
 
Chromatographic conditions: The HPLC analytical 
experiments were run on octadecyl silane C18 
chemically bonded column (Waters XBridge, 4.6×150 
mm, 5 μm). The mobile phase was a gradient of (0.5% 
acetic acid aqueous solution) (eluent A) with ACN 
(eluent B). The gradient elution was set for a liner 
gradient starting from 90% of eluent A and 10% eluent 
B up to 40% of eluent A and 60% of eluent B for 50 
minutes. Before the analysis, the column was 
equilibrated with the starting mobile phase for about 20 
min. All the solvents and sample were filtered with a 
0.45 m micro porous filter and were degassed by 
sonication prior to use. Wavelengths of 260 nm and 350 
nm were chosen since it was found that the Salvia 
palaestina compounds possess maximum absorption at 
these wavelengths. The flow rate was set at 1 mL/min. 
The injection volume was 10 L of 3 mg/mL and the 
temperature of the column was at room temperature.  
The HPLC Preparative experiments were run on 
ODS column (Agilent PrepHT C18, 22.2×250 mm, 10 
μm). The same mobile phase was used and the gradient 
elution was set for a liner gradient starting from (90% 
of eluent A and 10% eluent B) up to (50% of eluent A 
and 50% eluent B) for 20 minutes and then the 
preparative HPLC system was washed for 10 min with 
90% ACN to elute any lipophilic compounds from the 
column. The flow rate used was 15 mL/min, the 
injection volume was 1000 µL and the temperature of 
the column was at room temperature.  
 
Sample preparation: The sample solution of crude 
Salvia palaestina was prepared by dissolving about 75 
mg in 3 mL of 50% EtOH, shaken by mechanical 
means for 1 min, sonicated for 2 min and then was 
filtered using 0.45 m membrane filter before injection. 
The obtained final solution contained 25 mg/mL. One 
ml of this solution was directly injected to the 
preparative HPLC and eight fractions were collected.  
RESULTS AND DISCUSSION 
 
The results are shown as comparisons to positive 
and negative controls. Figure 1 shows the antimalarial 
activity of different dilutions of the alcoholic crude 
leaves extract of Salvia palaestina. The absorption is 
inversely proportional to drug efficiency; the lower the 
absorption is the more efficient the drug is. 
The antimalarial activity testing was repeated using 
a quantitative method; the results are presented in 
percentage yield (Fig. 2). The efficiency of crude 
extract as compared to positive control (chloroquine) 
and our positive internal control (2-MP) is shown in 
Fig. 3. 
Regardless of the mechanism of action of the 
extract of Salvia palaestina, it is clearly seen that the 
extract inhibits β-Hematin formation, however we 
believe it acts through a similar mechanism to 
chloroquine. 
In an attempt to isolate an active ingredient(s), 
several HPLC separation protocols were carried out 
resulting in eight fractions (Fig. 4 and 5), their 
individual effects are shown in Fig. 6. 
Sage is a rich source of polyphenols and has the 
ability to accumulate high levels of active flavonoids 
(Lu and Foo, 2002; Ulubelen and Tuzlaci, 1990). These 
classes of compounds are known to exhibit a range of 
biological activities including; anticancer, antibacterial, 
anti-oxidant and anti-inflammatory properties. High 
Performance Liquid Chromatography (HPLC) is the 
best technique to separate phenolic and triterpenoid 
compounds. 
Typical analytical HPLC chromatogram of the 
35% ethanolic crude mixture of Salvia palaestina 
revealed fourteen compounds at 260 and 350 nm. The 
overlaid UV spectra of the eluted peaks are shown in 
Fig. 4.  
Further step of purification was attained by loading 
1000 µL (25 mg/mL) 35% ethanolic crude extract of 
Salvia palaestina to inch preparative column and eluted 
subsequently using gradient binary solvent mixture of 
acidic water and ACN. Eight major fractions (I-VIII) 
with different concentrations were obtained as shown in 
Fig. 5. The aliquots collected were dried by using rotary 
evaporator to remove the acetonitrile solvent followed 
by direct freeze drying to get rid of the water and 
ending up with few mg’s of fluffy powdered material. 
As shown in Fig. 6 only three fractions were found 
to exhibit antimalarial activity when assayed in-vitro. 
We noticed that the most pharmacological potent 
fraction was fraction VII which was eluted between 
14.8-19 min. As shown in Fig. 5, this fraction contains 
a major peak at 15 min and to a lesser extent some other 
few peaks that lack chromophores which strengthens 
our  believe  that  this  compound is the one responsible 
for inhibitory effect on β-Hematin formation. Previous 
studies on other species of salvia leaves have proven 
the presence of phenolic compounds which possess 
strong UV-absorption chromophores (Lu and Foo, 
2002).  
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